Neurocrine Biosciences, Inc. (NBIX)
163.21
-0.67
(-0.41%)
USD |
NASDAQ |
Jun 08, 16:00
163.21
0.00 (0.00%)
After-Hours: 20:00
Neurocrine Biosciences Total Liabilities (Quarterly) : 1.499B for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Biogen, Inc. | 10.83B |
| Amgen, Inc. | 83.31B |
| Iovance Biotherapeutics, Inc. | 203.91M |
| Voyager Therapeutics, Inc. | 45.66M |
| Incyte Corp. | 1.716B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 4.906B |
| Shareholders Equity (Quarterly) | 3.407B |
| Debt to Equity Ratio | 0.1192 |
| Current Ratio | 2.929 |
| Net Debt Paydown Yield | 0.14% |